Targeting hepatic macrophages to treat liver diseases.

By F. Tacke. Journal of Hepatology, 2017

943 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/294a55210e03c88fb956deffa2214f99fabbc7b6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. L. Hammerich
2. M. Pinzani
3. M. Parola
4. F. Tacke

In Hepatology

1. L. Hammerich
2. M. Pinzani
3. M. Parola
4. F. Tacke

Citations in the corpus

• Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. (2019, background): “(Pellicoro et al., 2014; Seki and Schwabe, 2015; Krenkel and Tacke, 2017).”
• Hepatic inflammatory responses in liver fibrosis (2023, positive): “Inhibition of the CCR2–CCL2 chemokine pathway, which is critical for the recruitment of pro-inflammatory monocytes to the injured liver, with several different compounds having been shown to reduce liver pathology in preclinical studies 219 .”